Alfuzosin is a selective antagonist of post-synaptic alpha-1 adrenoreceptors, which relaxes muscles in the prostate and bladder neck. It is indicated for the treatment of functional symptoms of benign prostatic hyperplasia (BPH). This ingredient is a key component in many high-quality generic prostate treatments. Our UK pharmacy service offers secure access to medications containing Alfuzosin, providing patients with effective relief from urinary symptoms.
Alfuzosin belongs to a class of medicines called alpha-blockers. It works by relaxing the muscles in the prostate and the bladder neck, making it easier for urine to flow. In the UK, alfuzosin is the active ingredient in several prescription products, most notably Uroxatral and the generic version simply called Alfuzosin.
If you have been prescribed alfuzosin, you will most often receive it as Uroxatral tablets or as a generic alfuzosin tablet. Both are taken by mouth and are available in a standard strength of 10 mg. Uroxatral is marketed by a well-known pharmaceutical company, while the generic product is produced by a range of manufacturers and may appear under different pharmacy-brand names on the NHS prescription form. The tablets are usually round, film-coated, and designed for once-daily use. All of these products are authorised for use in England, Scotland, Wales and Northern Ireland.
Alfuzosin is primarily used to manage symptoms of an enlarged prostate, medically known as benign prostatic hyperplasia (BPH). BPH can cause:
By easing the tension in the prostate and surrounding muscle, alfuzosin helps relieve these bothersome signs. The medication is generally prescribed for adult men who experience moderate to severe BPH symptoms. While its main approved purpose is BPH, some clinicians may use alfuzosin in specific cases where bladder outlet obstruction is present, although this would be considered an off-label practice.
Alfuzosin targets receptors in smooth-muscle tissue that normally cause the muscle to contract. By blocking these receptors, the drug allows the muscles in the prostate and bladder neck to stay relaxed. This widening of the urinary passage reduces resistance to urine flow, which can improve the speed and completeness of voiding. Most people notice a change in symptoms within a few days, though the full benefit may take a couple of weeks to become apparent.
Many people taking alfuzosin experience only mild, temporary effects. Typical reports include:
These reactions often improve as the body adjusts to the medication.
Although rare, some reactions require urgent medical attention:
If any of these occur, seek emergency care right away.
Alfuzosin may not be suitable for everyone. People with the following conditions should discuss alternatives with their prescriber:
Pregnant or breastfeeding individuals are generally advised against using alfuzosin unless a specialist deems it essential.
Alfuzosin can interact with other medicines and substances:
For a full list of possible interactions, refer to the information page for the specific product you are using.
Store alfuzosin tablets in their original container, away from moisture and heat, and keep them out of reach of children. The usual course of treatment is long-term, as BPH symptoms often persist over many years. However, the exact length of therapy can vary between the brands Uroxatral and the generic version, so always follow the instructions that come with your specific prescription. Remember that this overview does not replace the detailed guidance printed on the medication label.
This article offers general educational information about alfuzosin as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing alfuzosin may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.
